chr1-155921437-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_014949.4(KHDC4):c.1204G>A(p.Val402Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000322 in 1,614,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/16 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_014949.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KHDC4 | NM_014949.4 | c.1204G>A | p.Val402Ile | missense_variant | 10/14 | ENST00000368321.8 | NP_055764.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KHDC4 | ENST00000368321.8 | c.1204G>A | p.Val402Ile | missense_variant | 10/14 | 1 | NM_014949.4 | ENSP00000357304.3 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000636 AC: 16AN: 251480Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135912
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461856Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 727234
GnomAD4 genome AF: 0.000210 AC: 32AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.000283 AC XY: 21AN XY: 74316
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2024 | The c.1204G>A (p.V402I) alteration is located in exon 10 (coding exon 10) of the KIAA0907 gene. This alteration results from a G to A substitution at nucleotide position 1204, causing the valine (V) at amino acid position 402 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at